More importantly, the relationship between IRF4 and immunity was evaluated from several significant aspects including TIICs (tumor-infiltrating immune cells), a pair of classic immune checkpoint genes comprising of a receptor and its ligand (PD1 and PDL1), as well as the tumor microenvironment. Here, IRF4 is linked to neoplasm.